Robotics in the healthcare and pharmaceutical sector has a relatively long history, having started with a robot called the Puma 560 in 1985, according to All About Robotic Surgery.
Now, however, a number of robotic and automation systems have been approved by the US Food and Drug Administration for operation in healthcare environments, and the market is probably set to grow exponentially in the next few years as they become fully commercialised.
The images show the “revolutionary” design of the robot, including its “highly versatile” surgical bio-mimicking arms.
The release of the photographs marks a major milestone, says CMR, which aims to make minimal access surgery available to all the estimated 6 million people a year who could benefit and make it easier for laparoscopic surgeons to learn and perform the technique. Continue reading Cambridge Medical unveils its new surgical robot
Surgical robots today are large and unwieldy. This causes a number of challenges in the operating theatre.
Setting up and managing the robots, for example, takes up valuable operating time. It’s also difficult to swap a robot in and out of a surgical procedure if traditional tools are more appropriate for some elements of an operation. And there are safety issues when clinical staff work in close proximity to a large piece of moving equipment.
So a surgeon has to weigh the benefits of surgical robotics against these limitations for each procedure where a robot is used.
In this exclusive article, Stuart Campbell, clinical sales development manager of the neurological products division at Renishaw, discusses key trends on the use of robotics in neurosurgery
The curious case of Phineas Gage is one of the earliest and most well known cases of serious brain injury. On September 13th, 1848, Gage was working as a railway foreman in Vermont when an explosion caused a three foot long iron rod to be propelled straight through his skull.
At the time, doctors thought it impossible to survive such an injury and his remarkable survival and reported personality changes affected the study of neuroscience forever. In recent years, a new technology is changing the face of neuroscience – robotics, which offers high precision access to a complex and sensitive region.
Intuitive Surgical and Shanghai Fosun Pharmaceutical have formed a joint venture to research, develop, manufacture and sell innovative, robotic-assisted catheter-based medical devices.
The joint venture between Intuitive Surgical, the global leader in robotic-assisted minimally invasive surgery, and Fosun Pharma, a leading healthcare group strategically comprising the complete value chain, will initially produce products targeting early diagnosis and cost-effective treatment of lung cancer, one of the most commonly diagnosed forms of cancer in the world.
Dr De Momi, of the Politecnico di Milano, in Italy, led an international team that trained a robot to imitate natural human actions. De Momi’s work indicates that humans and robots can effectively coordinate their actions during high-stakes events such as surgeries.
Various advanced tools and techniques have been implemented by orthopedic surgeons over the past decade to improve patient outcomes.
These tools and techniques help them in improving patient outcomes and offer comfort to patients during treatment. The orthopedic surgery robots use the 3D imaging technology and computer navigation techniques to improve ability of surgeons to place implants with precise alignment.
In this exclusive article for Robotics and Automation News, Chris Wagner, head of advanced surgical systems atCambridge Consultants, takes a microscopic look at the developments in medical robotics
This is an exciting time for medical robotics, as there is a proliferation of systems on the market or in development.
Intuitive Surgical’s da Vinci, the long-time market leader for robotic laparoscopic procedures, now has potential competition from Medtronic, Verb Surgical (backed by Google and J&J), Auris Surgical, Transenterix’s ALF-X, and Titan Medical’s Sport system.
Similarly, the orthopaedics robot market is active with Stryker’s Mako platform, Think Surgical’s TCAT system, Mazor Robotics Renaissance system for spine surgery, and Blue Belt Technologies (now owned by Smith & Nephew) Navio system.
Though Auris has not unveiled its much awaited endoscopy system, the recent approval from the Food and Drug Association has got many industry experts and principal investigator sharing their opinion
How many of us would actually trust a robotic surgeon operating on us? Not many. But the new precise and dexterous medical robot approved by the FDA shows they could soon take over the operation theater.
Within the next 10 years, scientists believe computer-assisted surgery will be a popular and a standard feature in many operation rooms and critical extension of modern medical professionals, say research analysts at Allied Market Research.
A team in Hong Kong is claiming to have developed the world’s first internally motorized minimally invasive surgical robotic system for single incision or natural orifice (incision-less) robotic surgery.
A statement by the the group, which comprises leading Hong Kong universities working with commercial partner companies, said the system can minimize surgical trauma and improve the safety of current robotic surgery.
The project is said to have developed a novel surgical robotic system (NSRS) with haptic (tactile) feedback and capable of single incision or natural orifice (incision-less) robotic surgery.